Criteo SA
CRTO · NASDAQ
About CRTO
- Employees
- 3,649
- Headquarters
- Paris, Ile-De-France
- Listed
- Oct 30, 2013
- Sector
- Communication Services
- Industry
- Media
- Website
- criteo.com
CRTO key statistics
- Market cap
- 754.07M
- Price-earnings ratio
- 7.76
- Dividend yield
- —
- Average volume
- 332.08K
- Volume
- 177.20K
- Open price
- $15.34
- High today
- $15.64
- Low today
- $15.25
- 52 Week high
- $22.72
- 52 Week low
- $14.28
Criteo SA (CRTO) at a glance
As of Oct 20, 2026, Criteo SA (CRTO) shares are priced at $15.39, giving the company a market cap of 754.07M and a price-to-earnings ratio of 7.76.
Today the stock has traded between $15.25 and $15.64. The current price is 0.9% above the day's low and 1.6% below its high.
Volume so far is 177.20K shares, below the average of 332.08K shares a day.
Over the past year Criteo SA has ranged from $14.28 to $22.72, and now sits 13% of the way up that range.
Criteo SA met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.80 per share against an estimate of $0.722.
The average analyst price target is $21.88, 42.1% above the current price, from 7 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy57.1%
- Hold42.9%
- Sell0.0%
- Low
- $14.14
- Now
- $15.39
- High
- $36.61
CRTO earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 26.2% on average.
- Q3 FY24: reported $0.96 per share against an estimate of $0.8462
- Q4 FY24: reported $1.75 per share against an estimate of $1.38
- Q1 FY25: reported $1.10 per share against an estimate of $0.7866
- Q2 FY25: reported $0.92 per share against an estimate of $0.7198
- Q3 FY25: reported $1.31 per share against an estimate of $0.9522
- Q4 FY25: reported $1.30 per share against an estimate of $1.43
- Q1 FY26: reported $0.73 per share against an estimate of $0.5765
- Q2 FY26: reported $0.80 per share against an estimate of $0.722
CRTO news
- Press releasePRNewswire
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Criteo S.A. - CRTO
- Press releaseBusiness Wire
Criteo Expands Regional Reach Through New Reseller Partnership with Tyroo
- Press releaseGlobe Newswire
CRTO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Criteo S.A.
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Criteo S.A. - CRTO
- Press releaseBusiness Wire
CRTO SHAREHOLDER ALERT: Criteo S.A. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
- Press releasePRNewswire
CRITEO TO PRESENT AT THE CITI 2026 GLOBAL TMT CONFERENCE ON SEPTEMBER 8, 2026
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. is Investigating Criteo S.A. on Behalf of Criteo Stockholders and Encourages Investors to Contact the Firm
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.